TREVICTA
As listed in the register: TREVICTA 175 mg, suspension injectable à libération prolongée
273 mg · suspension injectable à libération prolongée
- Prescription only
- Active substance
- Palmitate De Palipéridone
- Made by
- JANSSEN CILAG INTERNATIONAL NV
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Details
| Made by | JANSSEN CILAG INTERNATIONAL NV |
|---|---|
| Active substance | Palmitate De Palipéridone |
| Strength | 273 mg |
| Form | suspension injectable à libération prolongée |
| Route | intramusculaire |
| Dispensing (as stated by the register) | prescription réservée aux spécialistes et services PSYCHIATRIE · prescription initiale réservée à certains spécialistes · liste I · renouvellement non restreint |
| Marketed | Yes, according to the register |
| Authorisation procedure | Procédure centralisée |
| EU number | EU/1/14/971 |
| Name in the register | TREVICTA 175 mg, suspension injectable à libération prolongée |
| Packs | 1 seringue préremplie en copolymère de cyclooléfines de 0,875 ml (200 mg/ml) avec 2 aiguilles |
| CIS | 68924929 |
| CIP13 | 3400930059814 |
Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician
Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).
Other strengths and forms
4 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.